What is PSA (Prostate-specific Antigen)?

PSA is a protein produced by the prostate gland that serves as a key biomarker for prostate health, with levels typically under 4.0 ng/mL considered normal. Regular PSA testing helps detect prostate cancer early and monitor other prostate conditions, though elevated levels don't always indicate cancer.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding PSA: Your Prostate Health Indicator

Prostate-specific antigen (PSA) is a protein produced by both normal and malignant cells in the prostate gland, a small walnut-sized organ that sits below the bladder in men. This biomarker has become one of the most important tools in men's health screening, particularly for detecting prostate cancer and monitoring prostate health. While PSA naturally exists in small amounts in the bloodstream of healthy men, elevated levels can signal various prostate conditions that warrant further investigation.

The discovery and implementation of PSA testing revolutionized prostate cancer screening in the late 1980s and early 1990s. Before PSA testing became widely available, prostate cancer was often detected only after it had advanced to later stages. Today, PSA testing allows for much earlier detection, when treatment options are most effective and outcomes are generally better.

How PSA Functions in Your Body

PSA is an enzyme called a serine protease, primarily responsible for liquefying semen after ejaculation. This liquefaction process is crucial for sperm mobility and fertility. The prostate gland continuously produces PSA, and small amounts normally leak into the bloodstream. The epithelial cells lining the prostate ducts and acini are the primary producers of this protein.

Age-Adjusted PSA Reference Ranges

These ranges are guidelines; individual variation exists and PSA velocity may be more important than absolute values.
Age RangeNormal PSA RangeBorderline RangeAction Recommended
40-49 years40-49 years0-2.5 ng/mL2.5-3.0 ng/mLBaseline testing, repeat in 2 years if normal
50-59 years50-59 years0-3.5 ng/mL3.5-4.0 ng/mLAnnual or biennial testing based on level
60-69 years60-69 years0-4.5 ng/mL4.5-5.0 ng/mLAnnual testing, consider free PSA if borderline
70+ years70+ years0-6.5 ng/mL6.5-7.0 ng/mLIndividualized based on health status

These ranges are guidelines; individual variation exists and PSA velocity may be more important than absolute values.

In healthy prostate tissue, most PSA remains within the prostate and seminal fluid. However, when the prostate becomes enlarged, inflamed, or develops cancerous cells, the normal barriers between the prostate and bloodstream can break down, allowing more PSA to enter the circulation. This is why blood PSA levels serve as a valuable indicator of prostate health status.

Types of PSA in Your Blood

PSA exists in two main forms in the bloodstream:

  • Free PSA: This form circulates unbound to other proteins and typically represents 10-30% of total PSA
  • Bound PSA: This form is attached to proteins like alpha-1-antichymotrypsin and alpha-2-macroglobulin
  • Total PSA: The combination of both free and bound PSA, which is what standard PSA tests measure

The ratio of free to total PSA can provide additional diagnostic information. Men with prostate cancer tend to have a lower percentage of free PSA compared to those with benign conditions. This ratio becomes particularly useful when total PSA levels fall in the borderline range of 4-10 ng/mL.

Normal PSA Levels and What They Mean

Understanding what constitutes a normal PSA level is crucial for interpreting test results. PSA levels are measured in nanograms per milliliter (ng/mL) of blood. While there's no single "normal" PSA level for all men, medical professionals use age-adjusted reference ranges because PSA levels naturally increase with age.

It's important to note that these are general guidelines, and what's normal can vary based on individual factors. Some men naturally have higher PSA levels without any prostate problems, while others may develop prostate cancer with PSA levels below 4.0 ng/mL. This is why tracking PSA levels over time (PSA velocity) and considering other risk factors is often more informative than a single measurement.

Factors That Influence PSA Levels

Several factors can cause temporary or persistent elevations in PSA levels without indicating cancer:

  • Benign prostatic hyperplasia (BPH): Non-cancerous prostate enlargement common in aging men
  • Prostatitis: Inflammation or infection of the prostate
  • Recent ejaculation: Can raise PSA levels for 24-48 hours
  • Vigorous exercise: Particularly cycling, which puts pressure on the prostate
  • Digital rectal exam (DRE): Can cause minor, temporary elevations
  • Urinary tract infections: Can cause inflammation affecting PSA levels
  • Recent prostate biopsy or surgery: Can significantly elevate PSA for weeks

PSA Testing Methods and Procedures

PSA testing is a simple blood test that can be performed in various settings. The standard PSA test measures total PSA levels, while more specialized tests can measure free PSA or calculate PSA density and velocity. Understanding these different testing approaches helps you and your healthcare provider make more informed decisions about your prostate health monitoring.

When to Get PSA Testing

Current screening guidelines vary among medical organizations, but most recommend discussing PSA testing with your healthcare provider based on your individual risk factors:

  • Average-risk men: Consider starting discussions about PSA testing at age 50
  • High-risk men (African American or family history of prostate cancer): Consider starting at age 45
  • Very high-risk men (multiple family members with prostate cancer): Consider starting at age 40
  • Men over 70: Screening decisions should be individualized based on overall health and life expectancy

The frequency of PSA testing depends on your baseline levels and risk factors. Men with PSA levels below 2.5 ng/mL may only need testing every two years, while those with higher levels might benefit from annual testing.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Interpreting Elevated PSA Results

An elevated PSA level doesn't automatically mean prostate cancer. In fact, only about 25% of men with PSA levels between 4-10 ng/mL actually have prostate cancer. When PSA levels are elevated, healthcare providers consider several additional factors to determine the next steps.

Additional Diagnostic Tools

When PSA levels are concerning, several additional tests can help clarify the situation:

  • PSA velocity: The rate of PSA increase over time (concerning if >0.75 ng/mL per year)
  • PSA density: PSA level divided by prostate volume (higher density suggests increased cancer risk)
  • Free PSA percentage: Lower percentages (<10%) suggest higher cancer risk
  • 4Kscore test: Combines four kallikrein markers for improved risk assessment
  • Prostate Health Index (PHI): Combines total PSA, free PSA, and p2PSA
  • MRI imaging: Can identify suspicious areas before biopsy
  • Prostate biopsy: The definitive test for diagnosing prostate cancer

PSA and Prostate Cancer Risk

While PSA testing has significantly improved early detection of prostate cancer, it's important to understand both its benefits and limitations. PSA testing can detect prostate cancer 5-10 years before symptoms develop, when treatment is most effective. However, PSA testing can also lead to overdiagnosis of slow-growing cancers that might never cause symptoms or require treatment.

The relationship between PSA levels and prostate cancer risk is complex. While higher PSA levels generally indicate increased risk, some aggressive prostate cancers produce relatively little PSA. Conversely, many men with elevated PSA levels never develop prostate cancer. This is why PSA testing is best viewed as one tool among many for assessing prostate health, rather than a definitive diagnostic test.

Risk Stratification Based on PSA

Healthcare providers use PSA levels along with other factors to stratify cancer risk:

  • PSA <2.5 ng/mL: Low risk, especially if stable over time
  • PSA 2.5-4.0 ng/mL: Borderline risk, consider age and other factors
  • PSA 4.0-10.0 ng/mL: Moderate risk, often called the "gray zone"
  • PSA >10.0 ng/mL: High risk, further evaluation strongly recommended
  • PSA >20.0 ng/mL: Very high risk, often indicates advanced disease

Managing and Monitoring Your PSA Levels

While you can't directly control your PSA levels, certain lifestyle factors may help maintain prostate health and potentially influence PSA readings. Regular monitoring and a proactive approach to prostate health can help detect problems early when they're most treatable.

Lifestyle Factors for Prostate Health

Research suggests several lifestyle modifications may support prostate health:

  • Maintain a healthy diet rich in vegetables, particularly tomatoes (lycopene) and cruciferous vegetables
  • Exercise regularly, aiming for at least 150 minutes of moderate activity weekly
  • Maintain a healthy weight, as obesity is linked to more aggressive prostate cancers
  • Limit red meat and high-fat dairy consumption
  • Consider foods rich in omega-3 fatty acids like fish and nuts
  • Stay hydrated and limit alcohol consumption
  • Manage stress through relaxation techniques or counseling

Some studies suggest that certain supplements like vitamin D, selenium, and green tea extract may support prostate health, though evidence remains mixed. Always consult with your healthcare provider before starting any supplement regimen.

The Future of PSA Testing and Prostate Health Monitoring

The field of prostate cancer detection continues to evolve beyond traditional PSA testing. Researchers are developing new biomarkers and testing methods that may provide more accurate risk assessment. These include genetic tests that identify inherited risk factors, urine tests that detect specific cancer markers, and advanced imaging techniques that can better visualize prostate abnormalities.

Artificial intelligence and machine learning are also being applied to PSA data analysis, helping to identify patterns that might predict cancer risk more accurately than PSA levels alone. These advances promise to make prostate cancer screening more precise, reducing both missed cancers and unnecessary biopsies.

Taking Control of Your Prostate Health

Understanding PSA and its role in prostate health empowers you to make informed decisions about screening and monitoring. While PSA testing has limitations, it remains a valuable tool when used appropriately and in conjunction with other assessments. Regular monitoring, especially for men at higher risk, can lead to early detection when treatment options are most effective and outcomes are best.

Remember that PSA testing is just one component of comprehensive prostate health management. Open communication with your healthcare provider, awareness of your risk factors, and a proactive approach to overall health all contribute to optimal outcomes. Whether you're just beginning to think about prostate health screening or actively monitoring PSA levels, staying informed and engaged in your healthcare decisions is the best strategy for long-term wellness.

References

  1. Catalona, W. J., et al. (2023). Prostate cancer screening with prostate-specific antigen: A critical review of current evidence. Journal of Urology, 209(1), 45-53.[Link][DOI]
  2. US Preventive Services Task Force. (2018). Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 319(18), 1901-1913.[Link][PubMed][DOI]
  3. Loeb, S., et al. (2022). The Prostate Health Index: a new test for the detection of prostate cancer. Therapeutic Advances in Urology, 14, 1-12.[PubMed][DOI]
  4. Vickers, A. J., et al. (2019). The relationship between prostate-specific antigen and prostate cancer risk: The Prostate Biopsy Collaborative Group. Clinical Cancer Research, 25(22), 6817-6824.[Link][PubMed][DOI]
  5. Mottet, N., et al. (2021). EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Urology, 79(2), 243-262.[Link][PubMed][DOI]
  6. Thompson, I. M., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. New England Journal of Medicine, 350(22), 2239-2246.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my PSA at home?

You can test your PSA at home with SiPhox Health's Hormone Focus Program, which includes PSA testing along with other key hormone biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home with regular monitoring options.

What is the normal PSA range for men?

Normal PSA ranges vary by age: men in their 40s typically have PSA levels below 2.5 ng/mL, men in their 50s below 3.5 ng/mL, men in their 60s below 4.5 ng/mL, and men 70+ below 6.5 ng/mL. However, individual variation exists and trends over time matter more than single readings.

Can PSA levels fluctuate naturally?

Yes, PSA levels can fluctuate due to various factors including recent ejaculation (can elevate for 24-48 hours), vigorous exercise especially cycling, urinary tract infections, prostatitis, and even digital rectal exams. This is why doctors often repeat elevated tests before recommending further action.

Does an elevated PSA always mean cancer?

No, elevated PSA doesn't always indicate cancer. Only about 25% of men with PSA levels between 4-10 ng/mL have prostate cancer. Other common causes include benign prostatic hyperplasia (BPH), prostatitis, recent sexual activity, or urinary infections.

How often should I get my PSA tested?

Testing frequency depends on your baseline PSA and risk factors. Men with PSA below 2.5 ng/mL may test every 2 years, while those with higher levels or risk factors might benefit from annual testing. Discuss your individual screening schedule with your healthcare provider.

What should I do if my PSA is elevated?

If your PSA is elevated, don't panic. Your doctor will likely recommend repeating the test, as levels can fluctuate. They may also order additional tests like free PSA percentage, PSA velocity calculations, or imaging studies before considering a biopsy to determine the cause.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details